Hudson Bay Capital Management LP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,557,680
-9.6%
2,597,000
+96.0%
0.01%
-53.8%
Q2 2023$1,722,500
-57.0%
1,325,000
-41.8%
0.01%
-23.5%
Q1 2023$4,004,000
+10.2%
2,275,000
+96.5%
0.02%
-54.1%
Q4 2022$3,634,864
-17.6%
1,157,600
+28.6%
0.04%
-5.1%
Q3 2022$4,410,000
+12.1%
900,000
-5.3%
0.04%
+30.0%
Q2 2022$3,933,000
-18.5%
950,000
+14.5%
0.03%
-53.8%
Q1 2022$4,823,000
+7.2%
830,000
+38.3%
0.06%
+41.3%
Q4 2021$4,500,000
+5.1%
600,000
+26.3%
0.05%
-20.7%
Q3 2021$4,280,000
-20.5%
475,000
+5.6%
0.06%
-10.8%
Q2 2021$5,387,000
+28.3%
450,000
+34.3%
0.06%
+25.0%
Q1 2021$4,198,000
-62.6%
335,000
-53.5%
0.05%
-14.8%
Q4 2020$11,236,000
+147.7%
720,000
+50.0%
0.06%
-9.0%
Q3 2020$4,536,000
-2.6%
480,000
-7.7%
0.07%
-18.3%
Q2 2020$4,659,000
+8.3%
520,000
-23.0%
0.08%
-24.1%
Q1 2020$4,300,000
+97.6%
675,000
+159.6%
0.11%
+125.0%
Q4 2019$2,176,000
+33.6%
260,000
+44.4%
0.05%
+6.7%
Q3 2019$1,629,000
-24.4%
180,000
-10.0%
0.04%
-8.2%
Q2 2019$2,154,000
+653.1%
200,000
+566.7%
0.05%
+1125.0%
Q1 2019$286,000
-16.9%
30,0000.0%0.00%
-20.0%
Q4 2018$344,000
+1.5%
30,000
+50.0%
0.01%
+25.0%
Q3 2018$339,000
-20.4%
20,000
-33.3%
0.00%
-33.3%
Q2 2018$426,000
+7.6%
30,000
-33.3%
0.01%
-25.0%
Q2 2017$396,00045,0000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders